NovoCure Limited

Healthcare

NASDAQ:NVCR · NASDAQ Global Select

Market Cap $2.06B Beta 0.92 P/E (TTM) -11.7

$17.78 +0.40%

+$0.07 today

52W Low $9.82High $18.92

Vol 0.99M · Avg 1.50M

EPS (TTM)-$1.52

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+1.31%

Period High

$18.46

Period Low

$10.03

Latest

$17.78

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Establishment Labs Holdings Inc.

NASDAQ:ESTA

$2.42B

Neogen Corporation

NASDAQ:NEOG

$1.98B

Pulse Biosciences, Inc.

NASDAQ:PLSE

$1.69B

STAAR Surgical Company

NASDAQ:STAA

$1.41B

Teladoc Health, Inc.

NYSE:TDOC

$1.32B

BioLife Solutions, Inc.

NASDAQ:BLFS

$1.28B

Kestra Medical Technologies, Ltd.

NASDAQ:KMTS

$1.22B

Azenta, Inc.

NASDAQ:AZTA

$1.04B

Evotec SE

NASDAQ:EVO

$966.11M

Upstream Bio, Inc.

UPB

$331.96M

What is the latest NVCR filing?

The latest filing shown is 4 dated Jun 5, 2026.

How many recent filings does NVCR have?

Intrinsic Alpha currently shows 20 recent filings for NVCR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.